EUVIMEDOdkrijte EUVIMED
Crossref

Oxymatrine Alleviates Atherosclerosis by Regulating Macrophage Senescence via the SIRT1 ‐ P53 Signaling Pathway

Jun Xiang, Sheng-Quan Wang, Guang-Qiong Zhang, Li-Jin Jiao, Ling-Yun Fu, Yi-Ni Xu, Yu-Ying Wang, Xiang Li, Jun-Lu Tao, Xi-You Yang, Xiao-Shu Cha, Ling Tao and 1 more

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70209 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Jun Xiang and 12 co-authors. Institution: The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province, Guizhou Medical University, Guiyang, Guizhou, Ch…. Major MEDLINE topics: Matrines, Atherosclerosis, Macrophages, Cellular Senescence. 70 references. Funded by: National Natural Science Foundation of China, Guizhou Provincial Science and Technology projects, Guizhou Provincial Scientific and Technologic Innovation Base.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Recently, macrophage senescence has been identified as an important pathological risk factor for atherosclerosis (AS). Oxymatrine (OMT) has demonstrated potential in ameliorating cellular senescence. This study aims to investigate the pharmacological properties and underlying mechanisms of OMT in alleviating AS progression. High‐fat diet‐fed ApoE −/− mice and oxLDL‐induced macrophage senescence models were used to study OMT's effects in vivo and in vitro. Furthermore, OMT's mechanisms were investigated using network pharmacology, pharmacological intervention, gene silencing, molecular docking, Cellular Thermal Shift Assay (CETSA), and Drug Affinity Responsive Target Stability (DARTS) assays. The results demonstrated that OMT inhibited macrophage senescence, thereby improving AS progression. Network pharmacology analysis and biological experiments suggested that the mechanism of OMT improving AS is involving the regulation of SIRT1. Functional validation assays revealed that the effects of OMT were aborted by EX527 and SIRT1 shRNA. OMT enhanced the interaction between SIRT1 and P53, promoting P53 deacetylation and subsequent ubiquitination. Furthermore, Idasanutlin attenuated the functional effects of OMT, which indicated the pivotal role of P53. Molecular docking, CETSA, and DARTS assays confirmed that OMT directly binds to SIRT1 and stabilizes its protein. Our results highlight the potential anti‐atherosclerotic effects of OMT both in vitro and in vivo. Mechanistically, OMT stabilizes SIRT1, enhancing its activity to promote P53 deacetylation, ubiquitination, and degradation. Consequently, this process delays macrophage senescence‐induced foam cell formation, ultimately ameliorating AS. Our findings suggest OMT as a promising therapeutic candidate for AS.

Subjects

MeSH terms (MEDLINE)

MatrinesAtherosclerosisMacrophagesCellular SenescenceSirtuin 1Signal TransductionMaleAnimalsMiceMice, Inbred C57BLMolecular Docking SimulationTumor Suppressor Protein p53RAW 264.7 CellsHumansDiet, High-FatDisease Models, AnimalLipoproteins, LDL

Author keywords

atherosclerosischolesterol effluxfoam cellsmacrophage senescenceoxymatrinesirtuin 1

Substances

oxymatrineMatrinesSirt1 protein, mouseSirtuin 1Trp53 protein, mouseTumor Suppressor Protein p53oxidized low density lipoproteinLipoproteins, LDL

Authors and institutions

  • The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province, Guizhou Medical University, Guiyang, Guizhou, China.
  • The State Key Laboratory of Functions and Applications of Medicinal Plants, no. 6 Ankang Avenue, Guizhou Medical University, Guiyang, Guizhou, China.
  • The Key Laboratory of Optimal Utilization of Natural Medicine Resources, School of Pharmaceutical Sciences, Guizhou Medical University, Ankang, Guizhou, China.
  • Guizhou Provincial Key Laboratory of Pathogenesis and Prevention for Common Chronic Diseases, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
  • Department of Tuberculosis, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Funding

  • National Natural Science Foundation of China
  • Guizhou Provincial Science and Technology projects
  • Guizhou Provincial Scientific and Technologic Innovation Base

Cite

APA

Xiang, J., Wang, S. Q., Zhang, G. Q., Jiao, L. J., Fu, L. Y., Xu, Y. N., Wang, Y. Y., Li, X., Tao, J. L., Yang, X. Y., Cha, X. S., Tao, L., & Shen, X. C. (2026). Oxymatrine Alleviates Atherosclerosis by Regulating Macrophage Senescence via the SIRT1 ‐ P53 Signaling Pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.70209

Vancouver

Xiang J, Wang SQ, Zhang GQ, Jiao LJ, Fu LY, Xu YN, et al. Oxymatrine Alleviates Atherosclerosis by Regulating Macrophage Senescence via the SIRT1 ‐ P53 Signaling Pathway. Phytotherapy Research. 2026. doi:10.1002/ptr.70209

BibTeX
@article{Xiang2026,
  author = {Xiang, Jun and Wang, Sheng-Quan and Zhang, Guang-Qiong and Jiao, Li-Jin and Fu, Ling-Yun and Xu, Yi-Ni and Wang, Yu-Ying and Li, Xiang and Tao, Jun-Lu and Yang, Xi-You and Cha, Xiao-Shu and Tao, Ling and Shen, Xiang-Chun},
  title = {Oxymatrine Alleviates Atherosclerosis by Regulating Macrophage Senescence via the SIRT1 ‐ P53 Signaling Pathway},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70209}
}
Start for free →